Medical Condition News

RSS

Scientists identify key factor for limiting inflammatory responses, particularly in skin

Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online today in Immunity, provides clarity on how T cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis.

6 Dec 2013

Researchers take closer look at genetically engineered mouse models and human cancer samples

Researchers from the Fred Hutchinson Cancer Research Center in Seattle, WA have taken a closer look at existing mouse models of cancer, specifically comparing them to human cancer samples. These genetically engineered mouse models (which usually either overexpress a cancer-causing gene-or "oncogene"-or carry a deletion for a "tumor suppressor" gene) have been extensively used to understand human cancer biology in studies of drug resistance, early detection, metastasis, and cancer prevention, as well as for the preclinical development of novel targeted therapeutics.

6 Dec 2013

New findings by UCI, German researchers could aid in saving sight of millions

Groundbreaking new findings by UC Irvine and German chemists about how cataracts form could be used to help prevent the world's leading cause of blindness, which currently affects nearly 20 million people worldwide.

6 Dec 2013

Quadriplegics have heightened risk of central sleep apnea

There are over a million people with spinal cord injuries in the United States alone with an estimated 11,000 new cases every year. Furthermore, it is estimated that there are, at least, 100,000 veterans with SCI, making the VA the largest integrated health care system in the world for SCI care. But despite this large prevalence, researchers are still discovering all the various ways that SCI affect those with this condition beyond the obvious paralysis.

6 Dec 2013

Study shows it is not too late to stop smoking after cancer diagnosis

Men who continued to smoke after a cancer diagnosis had an increased risk of death compared with those who quit smoking after diagnosis, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

6 Dec 2013

Internet based intervention proves effective for people with PTSD, grief after loss of child during pregnancy

A paper published in the current issue of Psychotherapy and Psychosomatics reports on the usefulness of an internet based intervention on people who experienced grief after loss of a child during pregnancy.

6 Dec 2013

Patient survival higher among white children than minorities post liver transplant

Novel research reveals racial and socioeconomic disparities among pediatric liver transplant patients. Findings published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, indicate that graft and patient survival was higher in white children than minorities.

6 Dec 2013

Study examines correlation between polyunsaturated fatty acids in blood and risk of PTSD

A study published in the current issue of Psychotherapy and Psychosomatics has examined the correlation between polyunsaturated fatty acids in the blood and the risk of post-traumatic stress disorder.

6 Dec 2013

Telomerase inhibiting drug induces morphologic, molecular, clinical remissions in myelofibrosis patients

metelstat, a novel telomerase inhibiting drug, has been found to induce morphologic, molecular and clinical remissions in some patients with myelofibrosis a Mayo Clinic study has found. The results were presented today at the 2013 American Society of Hematology Annual Meeting in New Orleans.

6 Dec 2013

Professor investigates how residential environment factors may be linked to weight

The number of obese Americans is expected to increase to 113 million by the year 2022, making the U.S. the most overweight country in the world.

6 Dec 2013

ENC researchers point protein's role in prevention, management of type 2 diabetes

Nearly 26 million Americans have diabetes, costing an economically devastating $245 billion per year in medical costs. Projections suggest one in three Americans will have diabetes in 2050 if present trends continue.

6 Dec 2013

Cancer triggers scleroderma, shows evidence

Johns Hopkins scientists have found evidence that cancer triggers the autoimmune disease scleroderma, which causes thickening and hardening of the skin and widespread organ damage.

6 Dec 2013

Hypertension skyrocketing in India

Hypertension is skyrocketing in India, with rural-to-urban migrants at especially high risk. Hypertension will be a key theme at the 65th Annual Conference of the Cardiological Society of India, which takes place during 5-8 December in Bangalore, India, and features a collaborative programme with the European Society of Cardiology.

6 Dec 2013

Combination of preventive and therapeutic moxibustion has beneficial effect for Alzheimer's disease

An increasing number of clinical and animal studies have confirmed that acupuncture is effective for the treatment of Alzheimer's disease. Moxibustion is reported to be more effective than electro-acupuncture for improving space-recognizing memory ability in aged mice, suggesting that moxibustion is another alternative or complementary therapy used to treat Alzheimer's disease.

6 Dec 2013

Manipulation of Wnt/B-catenin pathway provides therapeutic targets for hair loss, skin cancer

A pathway known for its role in regulating adult stem cells has been shown to be important for hair follicle proliferation, but contrary to previous studies, is not required within hair follicle stem cells for their survival, according to researchers with the Perelman School of Medicine at the University of Pennsylvania.

5 Dec 2013

Cardiac patients benefit from home-based high intensity training

Rapid rehabilitation is a must after a heart attack or other cardiovascular event. Different forms of exercise as a part of rehabilitation have been examined by researchers, including high-intensity interval training (85-95 % of maximum heart rate), which has proved to be both a good and efficient form of rehabilitation.

5 Dec 2013

Study results show insulin sensitizers reduce risk of cancer in female patients with type 2 diabetes

A Cleveland Clinic-led study shows that a specific type of diabetes drug can decrease the risk of cancer in female patients with type 2 diabetes by up to 32 percent.

5 Dec 2013

CEL-SCI gets approval to start enrollment for Multikine Phase III study for head and neck cancer

Further advancing one of the largest Phase III trials for head and neck cancer in the world, CEL-SCI Corporation announced today that it has received approval from the Agency for Medicaments and Medical Devices of the government of Bosnia and Herzegovina to begin enrollment of subjects into the Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine (Leukocyte Interleukin, Injection).

5 Dec 2013

Presence Health uses automated IVR calls to increase colorectal cancer screening rates

Presence Health, the largest Catholic health system based in Illinois, significantly increased screening rates for colorectal cancer by utilizing automated, interactive voice response calls, according to research being presented on Dec. 10 at the Institute for Healthcare Improvement's 25th Annual National Forum on Quality Improvement in Health Care.

5 Dec 2013

AtheroNova completes active treatment portion of Phase 1 clinical trial with AHRO-001

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the completion of the active treatment portion of its Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study objective is to evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.

5 Dec 2013

Medical Condition News

Scientists identify key factor for limiting inflammatory responses, particularly in skin

Researchers take closer look at genetically engineered mouse models and human cancer samples

New findings by UCI, German researchers could aid in saving sight of millions

Quadriplegics have heightened risk of central sleep apnea

Study shows it is not too late to stop smoking after cancer diagnosis

Internet based intervention proves effective for people with PTSD, grief after loss of child during pregnancy

Patient survival higher among white children than minorities post liver transplant

Study examines correlation between polyunsaturated fatty acids in blood and risk of PTSD

Telomerase inhibiting drug induces morphologic, molecular, clinical remissions in myelofibrosis patients

Professor investigates how residential environment factors may be linked to weight

ENC researchers point protein's role in prevention, management of type 2 diabetes

Cancer triggers scleroderma, shows evidence

Hypertension skyrocketing in India

Combination of preventive and therapeutic moxibustion has beneficial effect for Alzheimer's disease

Manipulation of Wnt/B-catenin pathway provides therapeutic targets for hair loss, skin cancer

Cardiac patients benefit from home-based high intensity training

Study results show insulin sensitizers reduce risk of cancer in female patients with type 2 diabetes

CEL-SCI gets approval to start enrollment for Multikine Phase III study for head and neck cancer

Presence Health uses automated IVR calls to increase colorectal cancer screening rates

AtheroNova completes active treatment portion of Phase 1 clinical trial with AHRO-001

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News